Related references
Note: Only part of the references are listed.Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors
Samira M. Sadowski et al.
ENDOCRINE CONNECTIONS (2018)
Surgical aspects of neuroendocrine tumors of the small intestine
F. Weber et al.
CHIRURG (2018)
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
Ulrike Garske-Roman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis
Bo Zhou et al.
ONCOTARGETS AND THERAPY (2018)
Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms
Richard P. Baum et al.
Oncotarget (2018)
Assessment of the prognostic factors in patients with pulmonary carcinoid tumor: a population-based study
Yiwei Huang et al.
CANCER MEDICINE (2018)
Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study
Lunpo Wu et al.
ONCOTARGET (2017)
Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection
Paige Finkelstein et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
The prognostic influence of the proliferative discordance in metastatic pancreatic neuroendocrine carcinoma revealed by peptide receptor radionuclide therapy Case report and review of literature
Nathanaelle Montanier et al.
MEDICINE (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors
Lisa Bodei et al.
JOURNAL OF THORACIC DISEASE (2017)
Aggressive Surgical Resection in the Management of Pancreatic Neuroendocrine Tumors: When is it Indicated?
Pamela J. Hodul et al.
Cancer Control (2017)
Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis
L. M. Almond et al.
EJSO (2017)
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0, Tyr3] octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
Tessa Brabander et al.
CLINICAL CANCER RESEARCH (2017)
Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study
Jolanta Kunikowska et al.
ANNALS OF NUCLEAR MEDICINE (2017)
Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation
E. Bertani et al.
EJSO (2017)
Long-term results of PRRT in advanced bronchopulmonary carcinoid
Annapaola Mariniello et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases
Emilio Bertani et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
neat carcinoid tumors-small size belies deadly intent: high rate of nodal metastasis in tumors ≤1 cm in size
Joanna C. Walsh et al.
HUMAN PATHOLOGY (2016)
Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors
Giuseppe Lo Russo et al.
TUMOR BIOLOGY (2016)
[Lu-177-DOTA](0)-D-Phe(1)-Tyr(3)-Octreotide (Lu-177-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study
Richard P. Baum et al.
THERANOSTICS (2016)
Patient characteristics, treatment and survival in pulmonary carcinoid tumours: an analysis from the UK National Lung Cancer Audit
Stephanie Hobbins et al.
BMJ OPEN (2016)
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
M. E. Caplin et al.
ANNALS OF ONCOLOGY (2015)
Somatostatin Receptors in Bronchopulmonary Neuroendocrine Neoplasms: New Diagnostic, Prognostic, and Therapeutic Markers
Daniel Kaemmerer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
Samer Ezziddin et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Surgery for small-bowel neuroendocrine tumors: Is there any benefit of the laparoscopic approach?
Marleny N. Figueiredo et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2014)
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
Davide Campana et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Outcome of surgery for ileojejunal neuroendocrine tumors
Nils Habbe et al.
SURGERY TODAY (2013)
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases
G. Capurso et al.
BRITISH JOURNAL OF SURGERY (2012)
Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms
Richard P. Baum et al.
SEMINARS IN NUCLEAR MEDICINE (2012)
Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
Olov Norlen et al.
WORLD JOURNAL OF SURGERY (2012)
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
Richard P. Baum et al.
THERANOSTICS (2012)
Bronchopulmonary Carcinoid Tumors: Long-Term Outcomes After Resection
Christopher Cao et al.
ANNALS OF THORACIC SURGERY (2011)
Survival and prognostic factors in patients with small bowel carcinoid tumour
K. Landerholm et al.
BRITISH JOURNAL OF SURGERY (2011)
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Anna Imhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival
Dik J. Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Modeling cumulative incidence function for competing risks data
Mei-Jie Zhang et al.
Expert Review of Clinical Pharmacology (2008)
Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
Ji-Shiang Hung et al.
WORLD JOURNAL OF SURGERY (2007)
Surgery in malignant pancreatic neuroendocrine tumors
Scott Q. Nguyen et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Peptide receptor radionuclide therapy
Flavio Forrer et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors - An institutional experience
Paulus G. Schurr et al.
ANNALS OF SURGERY (2007)
Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas
Mark Bloomston et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors
Volker Fendrich et al.
ANNALS OF SURGERY (2006)
Surgical treatment of gastric, enteric, and pancreatic endocrine tumors - Part 1. Treatment of primary tumors
R Kianmanesh et al.
JOURNAL DE CHIRURGIE (2005)
Aggressive surgery for metastatic liver neuroendocrine tumors
JA Norton et al.
SURGERY (2003)
Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases
P Hellman et al.
WORLD JOURNAL OF SURGERY (2002)
Share Paper
